查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1852836

全球支氣管鏡市場按支氣管鏡類型、可重複使用性、技術、應用、最終用戶、分銷管道和患者年齡層分類－2025-2032 年預測

Bronchoscopy Market by Bronchoscope Type, Reusability, Technology, Application, End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，支氣管鏡市場規模將達到 101.4 億美元，複合年成長率為 11.00%。

主要市場統計數據
基準年2024年 43.9億美元
預計年份：2025年 48.7億美元
預測年份 2032 101.4億美元
複合年成長率（%） 11.00%

引言：一個框架，用於描述醫療保健環境中臨床需求、營運權衡以及設備創新與程序標準之間相互作用的演變。

支氣管鏡檢查融合了臨床需求、先進的影像技術和不斷發展的操作規格。臨床醫師依賴支氣管鏡進行各種干預，從下呼吸道的診斷性取樣到複雜性氣道疾病的治療。近年來，人們對支氣管鏡檢查的期望不斷提高，包括更高的診斷率、更短的操作時間和更佳的患者安全性，這促使設備、耗材和配套軟體平台不斷湧現出漸進式和顛覆性的創新。

醫院、門診手術中心和專科診所正在重新調整其資本和營運重點，以平衡高清視訊支氣管鏡和一次性支氣管鏡帶來的益處與感染控制需求和成本壓力。這一轉變的背景是醫保報銷機制的改變、日益嚴格的再處理規範以及對醫療設備環境和生命週期影響的日益關注。這些因素共同影響採購週期、庫存策略以及呼吸系統醫療設備、麻醉科、感染控制和供應鏈團隊之間的跨職能協調。

隨著相關人員不斷調整，策略選擇將取決於整合臨床結果、工作流程效率和長期營運風險的證據。本執行摘要探討了正在塑造支氣管內視鏡領域的變革性變化、近期貿易政策動態的影響、細分市場考量、區域差異化因素、競爭格局，並為希望駕馭日益複雜的支氣管內視鏡環境的領導者提供切實可行的建議。

清楚地描繪了技術、監管和醫療服務模式的轉變如何融合，並迅速重塑支氣管鏡檢查的操作流程、採購依據和臨床工作流程。

支氣管鏡領域正經歷著一場變革性的轉變，這主要得益於技術、感染控制和醫療服務模式等方面的整合。高解析度視訊支氣管鏡如今能夠為即時決策提供資訊，並支援超音波等輔助檢查方式；而光纖支氣管鏡系統在靈活性和低成本方面仍能滿足機構的實際需求。同樣，無菌一次性支氣管鏡的出現和成熟也正在重塑人們對器械再處理風險、週轉時間和資金配置的認知，使得一次性使用成為那些將感染預防和快速手術流程放在首位的醫療環境中的可行選擇。

同時，醫療服務模式正走向分散化。過去集中在三級醫院進行的醫療程序擴大在門診手術中心和診所進行，這改變了所需的設備、人員配置模式和物流。這種分散化趨勢，加上監管機構和醫療機構對再處理檢驗、環境永續性和基於價值的採購日益重視，促使醫院重新評估生命週期成本，而不僅僅是採購價格。數位化整合也產生了影響。改進的數據收集、手術記錄以及與電子健康記錄的互通性正成為採購委員會的決定性因素，將設備性能與品質指標和報銷策略掛鉤。

這些轉變絕非孤立發生，而是形成了一個反饋循環，加速了那些能夠顯著提高手術效率或降低感染風險的技術的普及，同時也迫使傳統製造商進行創新和合作。結果是，市場呈現出多元化的格局，臨床環境、醫院的優先事項以及不斷發展的循證依證將決定可重複使用系統和一次性替代方案之間的最佳平衡點。

本文深入分析了美國近期於2025年實施的關稅政策如何促使支氣管鏡相關人員進行採購調整、供應鏈多元化和策略性生產轉型。

2025年美國實施的關稅和貿易政策調整為支氣管鏡設備、耗材和零件的全球供應鏈帶來了實質的摩擦。關稅調整推高了設備和進口耗材的國內價格，迫使採購團隊重新評估供應商合約、庫存政策和總擁有成本計算。為此，一些供應商延長了設備更新周期，優先選擇國內供應商或免稅供應商，並尋求簽訂長期固定價格合約以降低短期價格波動的影響。

值得注意的是，關稅對不同產品類型的影響各不相同。依賴昂貴進口次組件的複雜資本設備比標準化的國產耗材面臨更大的利潤壓力。這促使人們對可在國內組裝的模組化設計產生了更大的興趣，並活性化了將關鍵製造環節轉移到更靠近終端市場的討論。關稅環境也增加了人們對一次性支氣管鏡的興趣，認為這是一種簡化採購流程並減少對跨境再加工耗材依賴的方法。然而，一次性儀器進口成本的增加在某些情況下可能會抵消營運效益，尤其是在缺乏規模經濟的情況下。

供應商的因應措施包括：拓展供應商基礎、增加區域庫存以及協商新的經銷條款，以維持利潤率和服務水準。醫療服務提供者的因應措施包括：加強需求預測，並與集團採購組織和區域聯盟達成合作協議。雖然關稅在短期內造成了採購摩擦，但也促使企業進行策略轉型，轉向增強供應鏈韌性、採用雙重採購策略以及選擇性近岸外包，以降低未來政策波動帶來的風險。

詳細的細分洞察揭示了支氣管鏡類型、可重複使用性、技術、臨床用途、最終用戶、分銷方式和患者年齡如何驅動不同的採用模式

從支氣管鏡類型、可重複使用性、技術、應用、最終用戶、通路和患者人口統計等方面進行分析，可以發現細分市場層面的動態變化，揭示了不同的價值促進因素和應用路徑。就支氣管鏡類型而言，膠囊支氣管鏡在特定診斷領域嶄露頭角；由於其操作性和操作者熟練度，軟式支氣管鏡在常規氣道操作中佔據主導地位；而硬式支氣管鏡對於某些需要穩定通道和大型器械的治療性操作至關重要。就可重複使用性而言，在手術量大、需要全面再處理和資本投入的情況下，可重複使用系統仍然具有優勢；而在感染控制至關重要、週轉速度快且消毒基礎設施有限的情況下，一次性支氣管鏡則更具吸引力。就技術而言，光纖支氣管鏡仍然是一種經濟高效且靈活的選擇；而在需要高品質影像、輔助攝影機整合和數位化記錄以進行高級診斷和培訓的情況下，視訊支氣管鏡則越來越受歡迎。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 機器人輔助精準肺部病灶取樣技術的應用日益廣泛。
  • 擴大人工智慧驅動的影像分析在支氣管鏡檢查的應用，以提高診斷準確性
  • 增加拋棄式支氣管鏡的使用，以降低感染風險和成本
  • 將周邊導航技術應用於支氣管鏡檢查中肺癌的早期檢測
  • 將超音波成像技術應用於切片檢查過程中以增強組織表徵
  • 開發用於即時3D導航的擴增實境引導支氣管鏡系統
  • 設備製造商和軟體供應商之間的合作，實現遠端支氣管鏡檢查

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 支氣管鏡市場（依支氣管鏡類型）

  • 膠囊
  • 靈活的
  • 死板的

第9章 支氣管鏡市場 重複使用性

  • 可重複使用的
  • 一次性的

第10章 依技術分類的支氣管鏡市場

  • 光纖
  • 影片

第11章 支氣管鏡市場依應用領域分類

  • 氣道清除
  • 診斷
    • 切片檢查
    • 支氣管肺泡灌洗
    • 支氣管超音波
  • 治療
    • 支氣管熱成形術
    • 去除異物
    • 雷射治療
    • 腫瘤消融

第12章 支氣管鏡市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院

第13章 支氣管鏡市場依通路分類

  • 直接地
  • 間接地

第14章 依病患年齡層分類的支氣管鏡市場

  • 成人
  • 孩子們

第15章 各地區支氣管鏡市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 支氣管鏡市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國支氣管鏡市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Olympus Corporation
    • Karl Storz SE & Co. KG
    • Fujifilm Holdings Corporation
    • HOYA Corporation
    • Ambu A/S
    • Boston Scientific Corporation
    • Medtronic plc
    • Richard Wolf GmbH
    • Smith & Nephew plc
    • ConMed Corporation
Product Code: MRR-3D2FD205D04C

The Bronchoscopy Market is projected to grow by USD 10.14 billion at a CAGR of 11.00% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.39 billion
Estimated Year [2025] USD 4.87 billion
Forecast Year [2032] USD 10.14 billion
CAGR (%) 11.00%

Introduction framing clinical imperatives, operational trade-offs, and the evolving interplay between device innovation and procedural standards across healthcare settings

Bronchoscopy stands at the intersection of clinical necessity, advancing imaging technology, and evolving procedural standards. Clinicians rely on bronchoscopy for a spectrum of interventions, from diagnostic sampling of the lower respiratory tract to therapeutic management of complex airway conditions. Over recent years, procedural expectations have shifted toward higher diagnostic yield, reduced procedural time, and enhanced patient safety, prompting both incremental and disruptive innovation across devices, disposables, and supporting software platforms.

Hospitals, ambulatory surgical centers, and specialty clinics are recalibrating capital and operational priorities to balance the benefits of high-definition video bronchoscopes and single-use disposables against infection-control imperatives and cost pressures. This transition is happening against a backdrop of changing reimbursement frameworks, more rigorous regulatory scrutiny of reprocessing practices, and growing attention to environmental and lifecycle impacts of medical devices. Together, these drivers influence procurement cycles, inventory strategies, and cross-departmental coordination between pulmonology, anesthesiology, infection control, and supply chain teams.

As stakeholders adapt, strategic choices hinge on evidence that integrates clinical outcomes, workflow efficiency, and long-term operational risk. The rest of this executive summary examines the transformative shifts shaping the landscape, the implications of recent trade policy dynamics, segmentation-specific insights, regional differentiators, competitive behaviors, and practical recommendations for leaders seeking to navigate an increasingly complex bronchoscopy environment.

Clear depiction of the converging technological, regulatory, and care delivery shifts that are rapidly redefining procedural practice, procurement rationales, and clinical workflows in bronchoscopy

The bronchoscopy landscape is experiencing transformative shifts driven by converging forces in technology, infection control, and care delivery models. Optical and video technologies have progressed from incremental improvements to enabling fundamentally different procedural workflows; higher-resolution video bronchoscopy now informs real-time decision-making and supports adjunctive modalities such as endobronchial ultrasound, while fiber optic systems retain a role where flexibility and lower cost align with facility constraints. Similarly, the advent and maturation of sterile single-use bronchoscopes have reframed conversations about reprocessing risk, turnaround time, and capital allocation, making disposability a viable option in environments where infection prevention or rapid procedural throughput is paramount.

Concurrently, care delivery has decentralized. Procedures once concentrated in tertiary hospitals are increasingly performed in ambulatory surgical centers and outpatient clinics, altering equipment requirements, staffing patterns, and supply logistics. This decentralization is coupled with heightened regulatory and institutional focus on reprocessing validation, environmental sustainability, and value-based procurement, prompting hospitals to reevaluate lifecycle costs rather than purchase price alone. Digital integration is also influential; improved data capture, procedural documentation, and interoperability with electronic health records are becoming deciding factors for purchasing committees, as they link device performance to quality metrics and reimbursement strategies.

Taken together, these shifts are not isolated; they create feedback loops that accelerate adoption of technologies that demonstrably improve procedural efficiency or reduce infection risk, while simultaneously compelling legacy manufacturers to innovate or partner. The result is a heterogeneous market in which clinical context, institutional priorities, and the evolving evidence base determine the optimal balance between reusable systems and single-use alternatives.

Nuanced analysis of how recent United States tariff actions in 2025 drove procurement recalibration, supply chain diversification, and strategic manufacturing shifts for bronchoscopy stakeholders

The imposition of tariffs and trade policy adjustments in the United States during 2025 introduced material frictions into global supply chains that supply bronchoscopy capital equipment, consumables, and subcomponents. Tariff adjustments amplified landed costs for equipment and imported disposables, prompting procurement teams to reassess vendor contracts, inventory policies, and total cost of ownership calculations. In response, some providers extended capital replacement cycles, prioritized domestic or tariff-exempt suppliers, and sought long-term fixed-price agreements to mitigate short-term volatility.

Importantly, tariffs have differentially affected product categories. Complex capital equipment that relies on high-value imported subassemblies experienced greater margin pressure than standardized, locally produced consumables. This has accelerated interest in modular designs that can be assembled domestically, and increased dialogue about relocating critical manufacturing steps closer to end markets. The tariff environment also heightened interest in single-use bronchoscopes as a way to simplify procurement and reduce reliance on cross-border reprocessing supplies; however, increased import costs for single-use devices in certain cases offset their operational advantages, especially where economies of scale are lacking.

Suppliers adapted by diversifying supplier bases, increasing regional stocking, and negotiating new distribution terms to preserve margin and maintain service levels. Healthcare providers responded by enhancing demand forecasting and by engaging in collaborative contracting with group purchasing organizations and regional consortia. While tariffs created near-term procurement friction, they also catalyzed strategic shifts toward supply chain resilience, dual-sourcing strategies, and selective nearshoring to reduce exposure to future policy volatility.

In-depth segmentation insights revealing how bronchoscope type, reusability, technology, clinical application, end user, distribution approach, and patient age drive differentiated adoption patterns

Segment-level dynamics reveal differentiated value drivers and adoption pathways when analyzed across bronchoscope type, reusability, technology, application, end user, distribution channel, and patient age group. Based on bronchoscope type, capsule forms are niche and emergent in specific diagnostic contexts, flexible bronchoscopes dominate in routine airway work due to maneuverability and operator familiarity, and rigid bronchoscopes remain indispensable for select therapeutic procedures requiring a stable channel and larger instrumentation. Based on reusability, reusable systems persist where high procedural volumes and full-service reprocessing capabilities justify capital investment, while single-use bronchoscopes appeal to settings prioritizing infection control, rapid turnover, or limited sterilization infrastructure. Based on technology, fiber optic bronchoscopes continue to offer cost-efficient, flexible options, whereas video bronchoscopes are increasingly preferred where image quality, ancillary camera integration, and digital documentation are required for advanced diagnostics and training.

Based on application, airway clearance procedures demand instruments optimized for suction and secretion management, diagnostic procedures emphasize devices that facilitate biopsy, bronchoalveolar lavage, and endobronchial ultrasound with precise sampling fidelity, and therapeutic applications require robust channels and compatibility with interventions such as bronchial thermoplasty, foreign body removal, laser therapy, and tumor ablation that place premium requirements on instrumentation and safety features. Based on end user, ambulatory surgical centers tend to favor single-use and lower-footprint systems that minimize turnaround complexity, clinics prioritize cost-effective flexible options for routine diagnostic work, and hospitals select a mix of reusable and high-performance video systems to support complex interventional programs and training. Based on distribution channel, direct arrangements enable tighter collaboration on device customization and service levels, whereas indirect channels offer broader reach and stock availability through distributor networks. Based on patient age group, adult procedures dominate volume and drive demand for a wide instrument range, while pediatric applications require scaled-down instrumentation, specialized training, and adaptations in sedation and airway management.

Understanding these segmentation contrasts allows stakeholders to align product development, service models, and commercial strategies to specific clinical and operational contexts rather than pursuing one-size-fits-all approaches.

Practical regional analysis showing how variations across the Americas, Europe Middle East & Africa, and Asia-Pacific shape procurement, regulatory expectations, and clinical adoption pathways

Regional dynamics exhibit pronounced differences that affect procurement decisions, regulatory expectations, and clinical adoption. In the Americas, a concentration of high-volume tertiary centers and a sizable ambulatory surgery market drive demand for both advanced video bronchoscopes and single-use options where infection control and throughput are priority considerations. Reimbursement frameworks and large-scale group purchasing arrangements in the region also shape contracting strategies and incentivize devices that demonstrably reduce procedure time or prevent costly complications.

In Europe, Middle East & Africa, heterogeneity is more pronounced. Western European markets emphasize rigorous reprocessing standards, environmental considerations, and interoperability with digital health systems, favoring reusable high-end video platforms alongside targeted single-use adoption. Middle Eastern and certain African markets demonstrate rapid investment in tertiary care capacity and interventional capabilities, creating growth pockets for both capital equipment and disposables. Throughout the EMEA region, regulatory convergence and heightened patient safety expectations influence procurement timelines and vendor qualification processes.

In Asia-Pacific, diverse healthcare infrastructures produce a broad spectrum of demand. High-growth urban centers are rapidly adopting cutting-edge imaging and interventional bronchoscopy capabilities, supported by domestic manufacturing ecosystems and growing investments in minimally invasive procedures. Simultaneously, other markets within the region prioritize accessible, cost-effective flexible systems and single-use solutions that reduce the burden on limited sterilization facilities. Across regions, the interplay between regulatory frameworks, local manufacturing capacity, and care delivery models determines the pace and shape of technology adoption.

Actionable corporate intelligence on how product differentiation, aftermarket services, and strategic partnerships are reshaping competitive dynamics and purchase criteria in bronchoscopy

Competitive behavior in the bronchoscopy ecosystem is driven by product differentiation, aftermarket services, and strategic partnerships that extend beyond device sales. Established original equipment manufacturers are investing in digital ecosystems that enhance procedural documentation, image management, and interoperability with hospital systems, while also refining service contracts to include training, reprocessing validation, and predictive maintenance. At the same time, a cohort of specialized manufacturers and newer entrants focuses on single-use bronchoscopes and disposable accessories, emphasizing simplified logistics and infection-prevention advantages that appeal to outpatient and resource-constrained settings.

Service providers and distributors play a pivotal role in broadening market access by providing managed inventory solutions, on-site service, and education programs that reduce the operational burden on clinical teams. Collaboration between manufacturers and third-party reprocessing specialists is evolving, with some partnerships aimed at delivering validated reprocessing protocols and others exploring hybrid approaches that integrate single-use and reusable assets. Strategic alliances between device manufacturers and software companies are also becoming more common, as analytics and procedural capture tools offer new value propositions tied to quality metrics and reimbursement documentation.

For procurement leaders and clinical champions, evaluating competitors requires scrutiny of product performance, but equally important is assessment of service footprint, training commitments, and the vendor's capacity to support regulatory compliance and supply continuity. The most successful companies combine technical innovation with a demonstrable ability to reduce operational complexity and align with institutional quality priorities.

Targeted recommendations for clinical, procurement, and executive leaders to optimize device selection, supply resilience, digital integration, training, and sustainability outcomes

Industry leaders can take pragmatic steps to align strategy with clinical needs, supply chain resilience, and sustainability expectations. First, prioritize evidence-based procurement by integrating clinical outcome data, reprocessing validation records, and real-world operational metrics to assess total cost and risk rather than focusing solely on unit price. Second, adopt flexible sourcing strategies that balance single-use and reusable assets according to procedure mix and infection control priorities, and consider pilot programs to evaluate workflow impact and staff training needs prior to large-scale deployment. Third, invest in supplier relationship management that secures service-level agreements, contingency stock arrangements, and collaborative demand forecasting to mitigate the effects of trade policies and logistical disruptions.

Fourth, pursue digital enablement by insisting on interoperability, procedural documentation capabilities, and analytics that link device performance to quality indicators and reimbursement workflows. Fifth, implement comprehensive training programs that reduce variability in device handling and optimize procedural throughput, thereby improving patient outcomes and enhancing return on investment. Sixth, incorporate environmental lifecycle assessments into procurement deliberations to balance infection-prevention imperatives against sustainability goals, exploring options for recyclable components or validated reprocessing where appropriate.

Finally, engage cross-functional stakeholders early-pulmonology, infection control, supply chain, finance, and biomedical engineering-to ensure that device selection aligns with clinical objectives, operational realities, and long-term strategic plans. These actions will position organizations to respond nimbly to technological advances and policy shifts while delivering consistent, high-quality care.

Methodological transparency explaining how primary interviews, rigorous secondary sources, triangulation, and quality assurance processes were combined to produce reliable and actionable bronchoscopy insights

This research synthesized evidence from multiple rigorous sources and employed a structured methodology designed to ensure validity, reproducibility, and practical relevance. Primary research included in-depth interviews with practicing pulmonologists, interventional bronchoscopists, sterile processing professionals, hospital procurement officers, and leaders of ambulatory surgical centers to capture frontline perspectives on device performance, workflow constraints, and purchasing criteria. Secondary research encompassed peer-reviewed clinical literature, regulatory guidance documents, device labeling and technical specifications, and publicly available guidance on reprocessing and infection control. Insights were triangulated across data types to mitigate bias and to align clinical narratives with device design attributes and operational realities.

Analytical methods included qualitative thematic analysis of interview transcripts to surface recurring operational pain points and adoption enablers, and comparative device feature mapping to assess how design choices translate into clinical and logistical outcomes. Risk assessments were conducted to evaluate supply chain vulnerabilities, regulatory compliance factors, and potential impacts of trade policy changes. Quality assurance steps included participant validation of key findings with selected clinical experts, cross-checking technical claims against manufacturer documentation and regulatory filings, and applying conservative inference rules when extrapolating operational implications from limited datasets. The methodology emphasizes transparency and replicability, positioning the findings as a reliable basis for strategic decision-making and for designing subsequent focused analyses or pilots.

Conclusive synthesis emphasizing the imperative for clinically informed procurement, supply chain resilience, and targeted adoption of technological and workflow innovations in bronchoscopy

The bronchoscopy field is in a period of pragmatic evolution: technology and workflow innovation are addressing long-standing clinical needs while policy and supply dynamics are compelling more sophisticated procurement and risk management approaches. Advances in video imaging, the emergence of viable single-use platforms, and the increasing expectation for digital procedural integration are changing the calculus for hospitals, ambulatory centers, and clinics. Meanwhile, trade policy shifts and supply chain disruptions have highlighted the importance of supplier diversification, near-term contingency planning, and closer alignment between clinical priorities and sourcing strategies.

These trends underscore the need for stakeholders to adopt nuanced, context-specific strategies that prioritize patient safety, procedural efficiency, and operational resilience. Organizations that successfully integrate clinical evidence, lifecycle cost assessment, and supply chain safeguards will be best positioned to harness technological advances while mitigating financial and operational risks. Ultimately, the most impactful decisions will be those that blend clinical leadership with disciplined procurement practices and a willingness to pilot new approaches that demonstrably improve outcomes and workflow.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of robotic-assisted bronchoscopy for precise pulmonary lesion sampling
  • 5.2. Growing application of AI-driven imaging analysis in bronchoscopic procedures for improved diagnostics
  • 5.3. Increasing utilization of disposable single-use bronchoscopes to reduce infection risk and costs
  • 5.4. Expansion of peripheral navigational technologies for early lung cancer detection in bronchoscopy
  • 5.5. Integration of endobronchial ultrasound elastography for enhanced tissue characterization during biopsies
  • 5.6. Development of augmented reality guided bronchoscopic systems for real-time 3D navigation
  • 5.7. Collaboration between device manufacturers and software vendors to enable tele-bronchoscopy capabilities in remote areas

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bronchoscopy Market, by Bronchoscope Type

  • 8.1. Capsule
  • 8.2. Flexible
  • 8.3. Rigid

9. Bronchoscopy Market, by Reusability

  • 9.1. Reusable
  • 9.2. Single Use

10. Bronchoscopy Market, by Technology

  • 10.1. Fiber Optic
  • 10.2. Video

11. Bronchoscopy Market, by Application

  • 11.1. Airway Clearance
  • 11.2. Diagnostic
    • 11.2.1. Biopsy
    • 11.2.2. Bronchoalveolar Lavage
    • 11.2.3. Endobronchial Ultrasound
  • 11.3. Therapeutic
    • 11.3.1. Bronchial Thermoplasty
    • 11.3.2. Foreign Body Removal
    • 11.3.3. Laser Therapy
    • 11.3.4. Tumor Ablation

12. Bronchoscopy Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Bronchoscopy Market, by Distribution Channel

  • 13.1. Direct
  • 13.2. Indirect

14. Bronchoscopy Market, by Patient Age Group

  • 14.1. Adult
  • 14.2. Pediatric

15. Bronchoscopy Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Bronchoscopy Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Bronchoscopy Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Olympus Corporation
    • 18.3.2. Karl Storz SE & Co. KG
    • 18.3.3. Fujifilm Holdings Corporation
    • 18.3.4. HOYA Corporation
    • 18.3.5. Ambu A/S
    • 18.3.6. Boston Scientific Corporation
    • 18.3.7. Medtronic plc
    • 18.3.8. Richard Wolf GmbH
    • 18.3.9. Smith & Nephew plc
    • 18.3.10. ConMed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRONCHOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRONCHOSCOPY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BRONCHOSCOPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS BRONCHOSCOPY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL BRONCHOSCOPY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. BRONCHOSCOPY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. BRONCHOSCOPY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BRONCHOSCOPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BRONCHOSCOPY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BRONCHOSCOPY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CAPSULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CAPSULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CAPSULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRONCHOSCOPY MARKET SIZE, BY RIGID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BRONCHOSCOPY MARKET SIZE, BY RIGID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRONCHOSCOPY MARKET SIZE, BY RIGID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BRONCHOSCOPY MARKET SIZE, BY RIGID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRONCHOSCOPY MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BRONCHOSCOPY MARKET SIZE, BY RIGID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRONCHOSCOPY MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BRONCHOSCOPY MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRONCHOSCOPY MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BRONCHOSCOPY MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRONCHOSCOPY MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BRONCHOSCOPY MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FIBER OPTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FIBER OPTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FIBER OPTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FIBER OPTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FIBER OPTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FIBER OPTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRONCHOSCOPY MARKET SIZE, BY VIDEO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BRONCHOSCOPY MARKET SIZE, BY VIDEO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRONCHOSCOPY MARKET SIZE, BY VIDEO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BRONCHOSCOPY MARKET SIZE, BY VIDEO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRONCHOSCOPY MARKET SIZE, BY VIDEO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BRONCHOSCOPY MARKET SIZE, BY VIDEO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AIRWAY CLEARANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AIRWAY CLEARANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AIRWAY CLEARANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AIRWAY CLEARANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AIRWAY CLEARANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AIRWAY CLEARANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOALVEOLAR LAVAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOALVEOLAR LAVAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOALVEOLAR LAVAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOALVEOLAR LAVAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOALVEOLAR LAVAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHOALVEOLAR LAVAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHIAL THERMOPLASTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHIAL THERMOPLASTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHIAL THERMOPLASTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHIAL THERMOPLASTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHIAL THERMOPLASTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BRONCHOSCOPY MARKET SIZE, BY BRONCHIAL THERMOPLASTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FOREIGN BODY REMOVAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FOREIGN BODY REMOVAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FOREIGN BODY REMOVAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FOREIGN BODY REMOVAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FOREIGN BODY REMOVAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BRONCHOSCOPY MARKET SIZE, BY FOREIGN BODY REMOVAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BRONCHOSCOPY MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BRONCHOSCOPY MARKET SIZE, BY LASER THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BRONCHOSCOPY MARKET SIZE, BY LASER THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BRONCHOSCOPY MARKET SIZE, BY LASER THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BRONCHOSCOPY MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BRONCHOSCOPY MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BRONCHOSCOPY MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BRONCHOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BRONCHOSCOPY MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BRONCHOSCOPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BRONCHOSCOPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BRONCHOSCOPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BRONCHOSCOPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BRONCHOSCOPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BRONCHOSCOPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BRONCHOSCOPY MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BRONCHOSCOPY MARKET SIZE, BY INDIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BRONCHOSCOPY MARKET SIZE, BY INDIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BRONCHOSCOPY MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BRONCHOSCOPY MARKET SIZE, BY INDIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BRONCHOSCOPY MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BRONCHOSCOPY MARKET SIZE, BY INDIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BRONCHOSCOPY MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BRONCHOSCOPY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BRONCHOSCOPY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS BRONCHOSCOPY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BRONCHOSCOPY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 329. GLOBAL BRONCHOSCOPY MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 330. GLOBAL BRONCHOSCOPY MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 331. ASEAN BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. ASEAN BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. ASEAN BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. ASEAN BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. ASEAN BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 336. ASEAN BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 340. ASEAN BRONCHOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 341. ASEAN BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 342. ASEAN BRONCHOSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 343. ASEAN BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 344. ASEAN BRONCHOSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 345. ASEAN BRONCHOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 346. ASEAN BRONCHOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 347. ASEAN BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 348. ASEAN BRONCHOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 349. ASEAN BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 350. ASEAN BRONCHOSCOPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 351. GCC BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 352. GCC BRONCHOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 353. GCC BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2018-2024 (USD MILLION)
  • TABLE 354. GCC BRONCHOSCOPY MARKET SIZE, BY BRONCHOSCOPE TYPE, 2025-2032 (USD MILLION)
  • TABLE 355. GCC BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 356. GCC BRONCHOSCOPY MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 357. GCC BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 358. GCC BRONCHOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 359. GCC BRON